Skip to content

SURMODICS INC

Delisted

CIK 924717fmd_1HVCTEJWTT8TJBMEGXD1XTAS0SManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: Oct 01, 2008 to Jun 30, 2025, 62 periods

Latest annual · FY2024

Millions
Total revenues
126
Gross profit
93
Operating income
(6)
Net income
(12)
Free cash flow
(3)

Latest quarter · Q3 FY2025

Millions
Total revenues
30
Gross profit
21
Operating income
(5)
Net income
(5)
Free cash flow
1
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2021 to FY2024
+6.2%
Revenue, 5 yearsFY2019 to FY2024
+4.7%
Net income, 5 yearsFY2019 to FY2024
n/m

SURMODICS INC financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2024FY2023ChangeSource
Revenue$126.1 million$132.6 million-4.9%10-K 2024-11-20 · proof
Gross profit$93.1 million$107.6 million-13.5%10-K 2024-11-20 · proof
Operating income-$5.6 million$5.2 million-209.6%10-K 2024-11-20 · proof
Net income-$11.5 million-$1.5 million10-K 2024-11-20 · proof
Cash from operating activities$248,000$10.5 million-97.6%10-K 2024-11-20 · proof
Free cash flow-$3.2 million$7.6 million-142.7%10-K 2024-11-20 · proof
Total assets$178.6 million$185.7 million-3.9%10-K 2024-11-20 · proof
Total liabilities$59.7 million$65.8 million-9.4%10-K 2024-11-20 · proof
Cash and cash equivalents$36.1 million$41.4 million-12.8%10-K 2024-11-20 · proof
What was SURMODICS INC's revenue in fiscal 2024?
SURMODICS INC reported revenue of $126.1 million for fiscal 2024 (the year ended Sep 30, 2024), against $132.6 million the year before (-4.9%). Source: the 10-K filed with the SEC on Nov 20, 2024. SEC
What was SURMODICS INC's gross profit in fiscal 2024?
SURMODICS INC reported gross profit of $93.1 million for fiscal 2024 (the year ended Sep 30, 2024), against $107.6 million the year before (-13.5%). Source: the 10-K filed with the SEC on Nov 20, 2024. SEC
What was SURMODICS INC's operating income in fiscal 2024?
SURMODICS INC reported operating income of -$5.6 million for fiscal 2024 (the year ended Sep 30, 2024), against $5.2 million the year before (-209.6%). Source: the 10-K filed with the SEC on Nov 20, 2024. SEC
What was SURMODICS INC's net income in fiscal 2024?
SURMODICS INC reported net income of -$11.5 million for fiscal 2024 (the year ended Sep 30, 2024), against -$1.5 million the year before. Source: the 10-K filed with the SEC on Nov 20, 2024. SEC
What was SURMODICS INC's cash from operating activities in fiscal 2024?
SURMODICS INC reported cash from operating activities of $248,000 for fiscal 2024 (the year ended Sep 30, 2024), against $10.5 million the year before (-97.6%). Source: the 10-K filed with the SEC on Nov 20, 2024. SEC
What was SURMODICS INC's free cash flow in fiscal 2024?
SURMODICS INC reported free cash flow of -$3.2 million for fiscal 2024 (the year ended Sep 30, 2024), against $7.6 million the year before (-142.7%). Source: the 10-K filed with the SEC on Nov 20, 2024. SEC
What are SURMODICS INC's total assets?
As of Sep 30, 2024, SURMODICS INC reported total assets of $178.6 million, against $185.7 million a year earlier (-3.9%). Source: the 10-K filed with the SEC on Nov 20, 2024. SEC
What are SURMODICS INC's total liabilities?
As of Sep 30, 2024, SURMODICS INC reported total liabilities of $59.7 million, against $65.8 million a year earlier (-9.4%). Source: the 10-K filed with the SEC on Nov 20, 2024. SEC
What are SURMODICS INC's cash and cash equivalents?
As of Sep 30, 2024, SURMODICS INC reported cash and cash equivalents of $36.1 million, against $41.4 million a year earlier (-12.8%). Source: the 10-K filed with the SEC on Nov 20, 2024. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:924717&period_type=annual&limit=5"

Information only, not investment advice.